Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 134

1.

Interlaboratory study to validate a STR profiling method for intraspecies identification of mouse cell lines.

Almeida JL, Dakic A, Kindig K, Kone M, Letham DLD, Langdon S, Peat R, Holding-Pillai J, Hall EM, Ladd M, Shaffer MD, Berg H, Li J, Wigger G, Lund S, Steffen CR, Fransway BB, Geraghty B, Natoli M, Bauer B, Gollin SM, Lewis DW, Reid Y.

PLoS One. 2019 Jun 20;14(6):e0218412. doi: 10.1371/journal.pone.0218412. eCollection 2019.

2.

Genomic and Transcriptomic Characterization Links Cell Lines with Aggressive Head and Neck Cancers.

Cheng H, Yang X, Si H, Saleh AD, Xiao W, Coupar J, Gollin SM, Ferris RL, Issaeva N, Yarbrough WG, Prince ME, Carey TE, Van Waes C, Chen Z.

Cell Rep. 2018 Oct 30;25(5):1332-1345.e5. doi: 10.1016/j.celrep.2018.10.007.

3.

Immunomodulatory drugs downregulate IKZF1 leading to expansion of hematopoietic progenitors with concomitant block of megakaryocytic maturation.

Liu A, Li S, Donnenberg V, Fu J, Gollin SM, Ma H, Lu C, Stolz DB, Mapara MY, Monaghan SA, Lentzsch S.

Haematologica. 2018 Oct;103(10):1688-1697. doi: 10.3324/haematol.2018.188227. Epub 2018 Jun 28.

4.

A prolonged response to platinum-based therapy in a patient with metastatic urothelial carcinoma harboring a single rearranged and truncated NF2 gene.

Achkar T, Ali SM, Welsh A, Dhir R, Gollin SM, Parikh RA.

Genes Chromosomes Cancer. 2018 Aug;57(8):430-433. doi: 10.1002/gcc.22537. Epub 2018 Mar 30.

PMID:
29532557
5.

Integration of high-risk human papillomavirus into cellular cancer-related genes in head and neck cancer cell lines.

Walline HM, Goudsmit CM, McHugh JB, Tang AL, Owen JH, Teh BT, McKean E, Glover TW, Graham MP, Prince ME, Chepeha DB, Chinn SB, Ferris RL, Gollin SM, Hoffmann TK, Bier H, Brakenhoff R, Bradford CR, Carey TE; University of Michigan Head and Neck Specialized Program of Research Excellence (SPORE) Program.

Head Neck. 2017 May;39(5):840-852. doi: 10.1002/hed.24729. Epub 2017 Feb 25.

6.

The Genomic Landscape of PAX5, IKZF1, and CDKN2A/B Alterations in B-Cell Precursor Acute Lymphoblastic Leukemia.

Ou Z, Sherer M, Casey J, Bakos HA, Vitullo K, Hu J, Friehling E, Gollin SM, Surti U, Yatsenko SA.

Cytogenet Genome Res. 2016;150(3-4):242-252. doi: 10.1159/000456572. Epub 2017 Feb 18.

PMID:
28214896
7.

Prevalence of HPV Infection in Racial-Ethnic Subgroups of Head and Neck Cancer Patients.

Ragin C, Liu JC, Jones G, Shoyele O, Sowunmi B, Kennett R, Groen HJ, Gibbs D, Blackman E, Esan M, Brandwein MS, Devarajan K, Bussu F, Chernock R, Chien CY, Cohen MA, Samir EM, Mikio S, D'Souza G, Funchain P, Eng C, Gollin SM, Hong A, Jung YS, Krüger M, Lewis J Jr, Morbini P, Landolfo S, Rittà M, Straetmans J, Szarka K, Tachezy R, Worden FP, Nelson D, Gathere S, Taioli E.

Carcinogenesis. 2016 Dec 26. pii: bgw203. doi: 10.1093/carcin/bgw203. [Epub ahead of print]

8.

Identification, expansion and characterization of cancer cells with stem cell properties from head and neck squamous cell carcinomas.

Kaseb HO, Fohrer-Ting H, Lewis DW, Lagasse E, Gollin SM.

Exp Cell Res. 2016 Oct 15;348(1):75-86. doi: 10.1016/j.yexcr.2016.09.003. Epub 2016 Sep 9.

9.

Cell division patterns and chromosomal segregation defects in oral cancer stem cells.

Kaseb HO, Lewis DW, Saunders WS, Gollin SM.

Genes Chromosomes Cancer. 2016 Sep;55(9):694-709. doi: 10.1002/gcc.22371. Epub 2016 Jun 23.

PMID:
27123539
10.

Correlation of Classic and Molecular Cytogenetic Alterations in Soft-Tissue Sarcomas: Analysis of 46 Tumors With Emphasis on Adipocytic Tumors and Synovial Sarcoma.

Rao UN, Cieply K, Sherer C, Surti U, Gollin SM.

Appl Immunohistochem Mol Morphol. 2017 Mar;25(3):168-177. doi: 10.1097/PAI.0000000000000294.

PMID:
26808135
11.

Integration of microarray analysis into the clinical diagnosis of hematological malignancies: How much can we improve cytogenetic testing?

Peterson JF, Aggarwal N, Smith CA, Gollin SM, Surti U, Rajkovic A, Swerdlow SH, Yatsenko SA.

Oncotarget. 2015 Aug 7;6(22):18845-62.

12.

Concerning consequences of blocking Notch signaling in satellite muscle stem cells.

Kaseb HO, Gollin SM.

Front Cell Dev Biol. 2015 Feb 18;3:11. doi: 10.3389/fcell.2015.00011. eCollection 2015. No abstract available.

13.

Cytogenetic alterations and their molecular genetic correlates in head and neck squamous cell carcinoma: a next generation window to the biology of disease.

Gollin SM.

Genes Chromosomes Cancer. 2014 Dec;53(12):972-90. doi: 10.1002/gcc.22214. Epub 2014 Sep 3. Review.

PMID:
25183546
14.

Viral load, gene expression and mapping of viral integration sites in HPV16-associated HNSCC cell lines.

Olthof NC, Huebbers CU, Kolligs J, Henfling M, Ramaekers FC, Cornet I, van Lent-Albrechts JA, Stegmann AP, Silling S, Wieland U, Carey TE, Walline HM, Gollin SM, Hoffmann TK, de Winter J, Kremer B, Klussmann JP, Speel EJ.

Int J Cancer. 2015 Mar 1;136(5):E207-18. doi: 10.1002/ijc.29112. Epub 2014 Aug 14.

15.

Janet Davison Rowley, M.D. (1925–2013).

Gollin SM, Reshmi SC.

Am J Hum Genet. 2014 Jun 5;94(6):805-8. No abstract available.

16.

Targeted inhibition of ATR or CHEK1 reverses radioresistance in oral squamous cell carcinoma cells with distal chromosome arm 11q loss.

Sankunny M, Parikh RA, Lewis DW, Gooding WE, Saunders WS, Gollin SM.

Genes Chromosomes Cancer. 2014 Feb;53(2):129-43. doi: 10.1002/gcc.22125. Epub 2013 Nov 25.

17.

Upregulation of the ATR-CHEK1 pathway in oral squamous cell carcinomas.

Parikh RA, Appleman LJ, Bauman JE, Sankunny M, Lewis DW, Vlad A, Gollin SM.

Genes Chromosomes Cancer. 2014 Jan;53(1):25-37. doi: 10.1002/gcc.22115. Epub 2013 Oct 21.

18.

The p53-PUMA axis suppresses iPSC generation.

Li Y, Feng H, Gu H, Lewis DW, Yuan Y, Zhang L, Yu H, Zhang P, Cheng H, Miao W, Yuan W, Cheng SY, Gollin SM, Cheng T.

Nat Commun. 2013;4:2174. doi: 10.1038/ncomms3174.

19.

Longitudinal bone marrow evaluations for myelodysplasia in patients with myeloma before and after treatment with lenalidomide.

Monaghan SA, Dai L, Mapara MY, Normolle DP, Gollin SM, Lentzsch S.

Leuk Lymphoma. 2013 Sep;54(9):1965-74. doi: 10.3109/10428194.2012.755177. Epub 2013 Jan 28.

20.

TMEM16A induces MAPK and contributes directly to tumorigenesis and cancer progression.

Duvvuri U, Shiwarski DJ, Xiao D, Bertrand C, Huang X, Edinger RS, Rock JR, Harfe BD, Henson BJ, Kunzelmann K, Schreiber R, Seethala RS, Egloff AM, Chen X, Lui VW, Grandis JR, Gollin SM.

Cancer Res. 2012 Jul 1;72(13):3270-81. doi: 10.1158/0008-5472.CAN-12-0475-T. Epub 2012 May 7.

21.

Quantitative chemical proteomics reveals new potential drug targets in head and neck cancer.

Wu Z, Doondeea JB, Gholami AM, Janning MC, Lemeer S, Kramer K, Eccles SA, Gollin SM, Grenman R, Walch A, Feller SM, Kuster B.

Mol Cell Proteomics. 2011 Dec;10(12):M111.011635. doi: 10.1074/mcp.M111.011635. Epub 2011 Sep 28.

22.

Myeloperoxidase-dependent oxidation of etoposide in human myeloid progenitor CD34+ cells.

Vlasova II, Feng WH, Goff JP, Giorgianni A, Do D, Gollin SM, Lewis DW, Kagan VE, Yalowich JC.

Mol Pharmacol. 2011 Mar;79(3):479-87. doi: 10.1124/mol.110.068718. Epub 2010 Nov 19.

23.

Overexpression of KLF13 and FGFR3 in oral cancer cells.

Henson BJ, Gollin SM.

Cytogenet Genome Res. 2010 Jun;128(4):192-8. doi: 10.1159/000308303. Epub 2010 Jun 2.

24.

Deficiency in myosin light-chain phosphorylation causes cytokinesis failure and multipolarity in cancer cells.

Wu Q, Sahasrabudhe RM, Luo LZ, Lewis DW, Gollin SM, Saunders WS.

Oncogene. 2010 Jul 22;29(29):4183-93. doi: 10.1038/onc.2010.165. Epub 2010 May 24.

25.

Polymorphisms in DNA damage response genes and head and neck cancer risk.

Flores-Obando RE, Gollin SM, Ragin CC.

Biomarkers. 2010 Aug;15(5):379-99. doi: 10.3109/13547501003797664. Review.

26.

Defining the borders of splenic marginal zone lymphoma: a multiparameter study.

Dufresne SD, Felgar RE, Sargent RL, Surti U, Gollin SM, McPhail ED, Cook JR, Swerdlow SH.

Hum Pathol. 2010 Apr;41(4):540-51. doi: 10.1016/j.humpath.2009.09.007. Epub 2009 Dec 11.

27.

Sheddase activity of tumor necrosis factor-alpha converting enzyme is increased and prognostically valuable in head and neck cancer.

Ge L, Baskic D, Basse P, Vujanovic L, Unlu S, Yoneyama T, Vujanovic A, Han J, Bankovic D, Szczepanski MJ, Hunt JL, Herberman RB, Gollin SM, Ferris RL, Whiteside TL, Myers EN, Vujanovic NL.

Cancer Epidemiol Biomarkers Prev. 2009 Nov;18(11):2913-22. doi: 10.1158/1055-9965.EPI-08-0898. Epub 2009 Oct 20.

28.

Recurrence in oral and pharyngeal cancer is associated with quantitative MGMT promoter methylation.

Taioli E, Ragin C, Wang XH, Chen J, Langevin SM, Brown AR, Gollin SM, Garte S, Sobol RW.

BMC Cancer. 2009 Oct 6;9:354. doi: 10.1186/1471-2407-9-354.

29.

Decreased expression of miR-125b and miR-100 in oral cancer cells contributes to malignancy.

Henson BJ, Bhattacharjee S, O'Dee DM, Feingold E, Gollin SM.

Genes Chromosomes Cancer. 2009 Jul;48(7):569-82. doi: 10.1002/gcc.20666.

30.

Comparisons of high-risk cervical HPV infections in Caribbean and US populations.

Ragin CC, Watt A, Markovic N, Bunker CH, Edwards RP, Eckstein S, Fletcher H, Garwood D, Gollin SM, Jackson M, Patrick AL, Smikle M, Taioli E, Wheeler VW, Wilson JB, Younger N, McFarlane-Anderson N.

Infect Agent Cancer. 2009 Feb 10;4 Suppl 1:S9. doi: 10.1186/1750-9378-4-S1-S9.

31.

Knowledge about human papillomavirus and the HPV vaccine--a survey of the general population.

Ragin CC, Edwards RP, Jones J, Thurman NE, Hagan KL, Jones EA, Moss CM, Smith AC, Akers A, Gollin SM, Heron DE, Andraos-Selim C, Bondzi C, Robertson L, Taioli E.

Infect Agent Cancer. 2009 Feb 10;4 Suppl 1:S10. doi: 10.1186/1750-9378-4-S1-S10.

32.

Prevalence of cancer-associated viral infections in healthy afro-Caribbean populations: a review of the literature.

Ragin C, Edwards R, Heron DE, Kuo J, Wentzel E, Gollin SM, Taioli E.

Cancer Invest. 2008 Nov;26(9):936-47. doi: 10.1080/07357900801975280. Review.

PMID:
19034776
33.

A stochastic model for cancer stem cell origin in metastatic colon cancer.

Odoux C, Fohrer H, Hoppo T, Guzik L, Stolz DB, Lewis DW, Gollin SM, Gamblin TC, Geller DA, Lagasse E.

Cancer Res. 2008 Sep 1;68(17):6932-41. doi: 10.1158/0008-5472.CAN-07-5779.

34.

Fluorescence immunophenotypic and interphase cytogenetic characterization of nodal lymphoplasmacytic lymphoma.

Sargent RL, Cook JR, Aguilera NI, Surti U, Abbondanzo SL, Gollin SM, Swerdlow SH.

Am J Surg Pathol. 2008 Nov;32(11):1643-53. doi: 10.1097/PAS.0b013e3181758806.

PMID:
18670352
35.

Tissue engineering of oral dysplasia.

Gaballah K, Costea DE, Hills A, Gollin SM, Harrison P, Partridge M.

J Pathol. 2008 Jul;215(3):280-9. doi: 10.1002/path.2360.

PMID:
18484684
36.

Chemosensitization of head and neck cancer cells by PUMA.

Sun Q, Sakaida T, Yue W, Gollin SM, Yu J.

Mol Cancer Ther. 2007 Dec;6(12 Pt 1):3180-8.

37.

Chondromyxoid fibroma of rib with a novel chromosomal translocation: a report of four additional cases at unusual sites.

Armah HB, McGough RL, Goodman MA, Gollin SM, Surti U, Parwani AV, Rao UN.

Diagn Pathol. 2007 Nov 24;2:44.

38.

Distinct distribution of HPV types among cancer-free Afro-Caribbean women from Tobago.

Ragin CC, Wheeler VW, Wilson JB, Bunker CH, Gollin SM, Patrick AL, Taioli E.

Biomarkers. 2007 Sep-Oct;12(5):510-22.

PMID:
17701749
39.

Chromosomal imbalances in oral squamous cell carcinoma: examination of 31 cell lines and review of the literature.

Martin CL, Reshmi SC, Ried T, Gottberg W, Wilson JW, Reddy JK, Khanna P, Johnson JT, Myers EN, Gollin SM.

Oral Oncol. 2008 Apr;44(4):369-82. Epub 2007 Aug 2. Review.

40.

Loss of distal 11q is associated with DNA repair deficiency and reduced sensitivity to ionizing radiation in head and neck squamous cell carcinoma.

Parikh RA, White JS, Huang X, Schoppy DW, Baysal BE, Baskaran R, Bakkenist CJ, Saunders WS, Hsu LC, Romkes M, Gollin SM.

Genes Chromosomes Cancer. 2007 Aug;46(8):761-75.

PMID:
17492757
41.

Head and neck squamous cell carcinoma cell lines: established models and rationale for selection.

Lin CJ, Grandis JR, Carey TE, Gollin SM, Whiteside TL, Koch WM, Ferris RL, Lai SY.

Head Neck. 2007 Feb;29(2):163-88. Review.

42.

Inverted duplication pattern in anaphase bridges confirms the breakage-fusion-bridge (BFB) cycle model for 11q13 amplification.

Reshmi SC, Roychoudhury S, Yu Z, Feingold E, Potter D, Saunders WS, Gollin SM.

Cytogenet Genome Res. 2007;116(1-2):46-52.

PMID:
17268177
43.

The epidemiology and risk factors of head and neck cancer: a focus on human papillomavirus.

Ragin CC, Modugno F, Gollin SM.

J Dent Res. 2007 Feb;86(2):104-14. Review.

PMID:
17251508
44.

Mechanisms leading to nonrandom, nonhomologous chromosomal translocations in leukemia.

Gollin SM.

Semin Cancer Biol. 2007 Feb;17(1):74-9. Epub 2006 Oct 26. Review.

45.

The influence of clinical and demographic risk factors on the establishment of head and neck squamous cell carcinoma cell lines.

White JS, Weissfeld JL, Ragin CC, Rossie KM, Martin CL, Shuster M, Ishwad CS, Law JC, Myers EN, Johnson JT, Gollin SM.

Oral Oncol. 2007 Aug;43(7):701-12. Epub 2006 Nov 16.

46.

Relationship between FRA11F and 11q13 gene amplification in oral cancer.

Reshmi SC, Huang X, Schoppy DW, Black RC, Saunders WS, Smith DI, Gollin SM.

Genes Chromosomes Cancer. 2007 Feb;46(2):143-54.

PMID:
17099871
47.

Overexpression of glycosylphosphatidylinositol (GPI) transamidase subunits phosphatidylinositol glycan class T and/or GPI anchor attachment 1 induces tumorigenesis and contributes to invasion in human breast cancer.

Wu G, Guo Z, Chatterjee A, Huang X, Rubin E, Wu F, Mambo E, Chang X, Osada M, Sook Kim M, Moon C, Califano JA, Ratovitski EA, Gollin SM, Sukumar S, Sidransky D, Trink B.

Cancer Res. 2006 Oct 15;66(20):9829-36.

48.

11q13 amplification status and human papillomavirus in relation to p16 expression defines two distinct etiologies of head and neck tumours.

Ragin CC, Taioli E, Weissfeld JL, White JS, Rossie KM, Modugno F, Gollin SM.

Br J Cancer. 2006 Nov 20;95(10):1432-8. Epub 2006 Sep 26.

49.

Comprehensive genome and transcriptome analysis of the 11q13 amplicon in human oral cancer and synteny to the 7F5 amplicon in murine oral carcinoma.

Huang X, Godfrey TE, Gooding WE, McCarty KS Jr, Gollin SM.

Genes Chromosomes Cancer. 2006 Nov;45(11):1058-69.

PMID:
16906560
50.

Overexpression of Cdc20 leads to impairment of the spindle assembly checkpoint and aneuploidization in oral cancer.

Mondal G, Sengupta S, Panda CK, Gollin SM, Saunders WS, Roychoudhury S.

Carcinogenesis. 2007 Jan;28(1):81-92. Epub 2006 Jun 15.

PMID:
16777988

Supplemental Content

Loading ...
Support Center